Búsqueda

IDIOMA/LANGUAGE

Bandera inglesa Bandera espanola

Próximas Comunicaciones

SEOM

Sabater E, García San Andrés B, Oyagüez I, Fernández Santos JM

Trabectedina y doxorrubicina liposomal pegilada vs. Carboplatino y doxorrubicina liposomal pegilada en cáncer de ovario platino sensible tras recidiva temprana: análisis exploratorio de eficacia mediante el uso de matched adjusted indirect comparison

V Congreso de Oncología Médica y Farmacia...

SAD

Villanueva V, Presa M, Oyagüez I, Serrano M, Collar JM

Análisis Coste-Efectividad de Oxicodona/Naloxona vs Tapentadol en el tratamiento del dolor lumbar crónico con componente neuropático

XVI Jornada Aragonesa de Actualización en el Tratamiento del Dolor. XIII Reunión de la SAD. Zaragoza. 17-18 nov 2017

ISPOR

Sabater E, Puente J, Oyagüez I, García-Campelo R, Reguart N, Rodriguez D, Cobo M, Moran M, Soto J

Cost-effectiveness of sequential treatment containing crizotinib for non small cell lung cancer (ALK+) patients

20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

ISPOR

Mareque M, Oyagüez I, Morano R, Casado MA

Systematic review of herpes zoster epidemiology: available evidence in Spain related to specific sub-populations

20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

ISPOR

Mareque M, Mingot E, López MF, Álvarez MT, García JP, Oyagüez I

Bypassing agents prophylaxis in patients with haemophilia and inhibitors undergoing surgery: a decision analysis in Spain 

20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

ISPOR

Casado LF, Hernández JA, Jarque I, Echave M, Casado MA, Castro A

Cost-utility of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia

20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

ISPOR

Peral C, Gomez I, Burgos R , Rebollo F

Economic evaluations of etanercept in patients with psoriasis and psoriatic arthritis in Spain: a systematic review

20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017

ISPOR

Martínez-Sesmero JM, Burgos R, Jornet S, Santiago A, Navarro H, Gorgas Q, Jolonch P, Díaz Moreno V, Griffa L, Oyagüez I

Economic evaluation of a patient support programme Abbvie Care 2.0 Immunology

20th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow, Scotland. 4-8 nov 2017